ANGIOTENSIN RECEPTOR ANTAGONISTS: GOING WITH THE TIMES

Abstract

This literature review focuses on the angiotensin II receptor antagonists as one of the new and promising classes of antihypertensive medications. Apart from their antihypertensive activity, these agents possess a number of other beneficial effects. The results of multiple studies, including large multi-centre clinical trials, are presented for olmesartan, an angiotensin receptor antagonist with additional beneficial properties.

Keywords

• arterial hypertension
• metabolic syndrome
• elderly age
• olmesartan